Clinical Trial Update: Caffeine for Hypoxic Ischemic Encephalopathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating caffeine for Hypoxic Ischemic Encephalopathy and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: NICHD Global Network for Women's and Children's Health | Conditions: Hypoxic Ischemic Encephalopathy (HIE) | Phase 3 | Status: NOT_YET_RECRUITING